Skip to content
ABOUT
Company
Team
Board of Directors
Scientific Advisory Board
Advisors
Careers
PRODUCTS
PIPELINE
ExoPTEN
Spinal Cord Injury
Optic Nerve Injury
Road Map
PLATFORM
ExoTherapy
Exosomes
siRNA
Drug Delivery
Future Indications
Publications
Intellectual Property
COLLABORATIONS
INVESTORS
Stock Info
Financials & Filings
News
Events
Presentations
Analyst Coverage
Corporate Governance
MEDIA
Press Releases
Articles
Podcasts
Videos
ABOUT
Company
Team
Board of Directors
Scientific Advisory Board
Advisors
Careers
PRODUCTS
PIPELINE
ExoPTEN
Spinal Cord Injury
Optic Nerve Injury
Road Map
PLATFORM
ExoTherapy
Exosomes
siRNA
Drug Delivery
Future Indications
Publications
Intellectual Property
COLLABORATIONS
INVESTORS
Stock Info
Financials & Filings
News
Events
Presentations
Analyst Coverage
Corporate Governance
MEDIA
Press Releases
Articles
Podcasts
Videos
Exo-Top
Exo-Top
Q4FY22 Annual FS
Read More »
April 2, 2023
Q4FY22 Annual Information Form
Read More »
April 2, 2023
Q4FY22 Annual MD&A
Read More »
April 2, 2023
Management Information Circular
Read More »
February 26, 2023
Q2-2022 interim FS
Read More »
February 26, 2023
NurExone Biologic Inc @ interim FS
Read More »
February 26, 2023
Q3-2022 MD&A
Read More »
February 26, 2023
Q3-2022 interim FS
Read More »
February 26, 2023
Q2 2022 – Quarterly Report
Read More »
February 26, 2023
Q2-2022 MD&A
Read More »
December 19, 2022
« Previous
Page
1
Page
2
Next »
Careers
Collaborations
Company
Contact Us
Data Room
Data Room old
Enerspar
Eran Ovadya
Events
Events
Exo-Top
EXOPTEN
EXOPTEN: CNSI
ExoPTEN: Facial Nerve Damage
ExoPTEN: Glaucoma
ExoTherapy
Healthcare
Home
In The Media
Ina Sarel
Investor Webinar, Oct 20, 2022
Investors
IP
Jacob Licht Business Card
Lior Shaltiel
Pipeline
Podcast
Press Releases
Privacy Policy
PTEN
Road Map
Science
Scientific Articles
siRNA Sequences
Team
TERMS & CONDITIONS
The Science of ExoPTEN
Transaction in the Exosome filed
Videos
Yoram Drucker
Set layout popup
